Search research articles
Contact Us
Filters
Showing results (1141-1150 of 1,208) with videos related to
Page
of 121
Sort By:
The Journal of International Medical Research
|
January 1, 1982
Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study
F Ichida, K Shibasaki, T Takino, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter Baumannii
Brian M Ho, Jingxiu Jin, Jacob T Sanborn, et al.
The Lancet. Microbe
|
July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient care
Zackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Nature Immunology
|
March 23, 2001
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes
A Shibuya, N Sakamoto, Y Shimizu, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model
Zakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
The Journal of Antimicrobial Chemotherapy
|
September 17, 2016
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii
Justin R Lenhard, Jürgen B Bulitta, Terry D Connell, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity
Nicholas M Smith, Katie Rose Boissonneault, Liang Chen, et al.
Intensive Care Medicine
|
April 15, 2017
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T Tängdén, V Ramos Martín, T W Felton, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Page
of 121
Search research articles
Search
Showing results (1141-1150 of 1,208) with videos related to
Sort By:
Page
of 121
The Journal of International Medical Research
|
January 1, 1982
Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study
F Ichida, K Shibasaki, T Takino, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter Baumannii
Brian M Ho, Jingxiu Jin, Jacob T Sanborn, et al.
The Lancet. Microbe
|
July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient care
Zackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Nature Immunology
|
March 23, 2001
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes
A Shibuya, N Sakamoto, Y Shimizu, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model
Zakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
The Journal of Antimicrobial Chemotherapy
|
September 17, 2016
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii
Justin R Lenhard, Jürgen B Bulitta, Terry D Connell, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity
Nicholas M Smith, Katie Rose Boissonneault, Liang Chen, et al.
Intensive Care Medicine
|
April 15, 2017
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T Tängdén, V Ramos Martín, T W Felton, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Page
of 121